NG
NervGen Pharma Corp. Common stock (NGEN)
NASDAQ·Healthcare·Biotechnology
$3.91
+1.43%
Mkt Cap $317.25M
No analyst coverage available
We don't have analyst ratings or price target data for NervGen Pharma Corp. Common stock yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.